Fri 25 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| Brolucizumab | Beovu | 120 | Solution for injection | 2478.75 | Details |
| Obeticholic Acid | Ocaliva | 5 | Film-coated tablet | 9837.80 | Details |
| Obeticholic Acid | Ocaliva | 10 | Film-coated tablet | 9837.80 | Details |
| EZETIMIBE | Etimicol 10 | 10 | Tablet | 118.5 | Details |
| TRIENTINE DIHYDROCHLORIDE | Trientine dihydrochloride | 250 | Capsule, hard | 8450.10 | Details |
| Bevacizumab | Zirabev | 25 | Concentrate for solution for infusion | 741.65 | Details |
| Bevacizumab | Zirabev | 25 | Concentrate for solution for infusion | 2973.099 | Details |
| ADENOSINE | Xoria | 3 | Solution for injection | 110 | Details |
| Capecitabine | Pitacro | 150 | Tablet | 257.70 | Details |
| Capecitabine | Pitacro | 500 | Tablet | 859.05 | Details |
| ERLOTINIB | Tyrox | 25 | Film-coated tablet | 930.3 | Details |
| ERLOTINIB | Tyrox | 100 | Film-coated tablet | 3721.15 | Details |
| RIVAROXABAN | Rivaroxaban SPC | 10 | Film-coated tablet | 64.15 | Details |
| RIVAROXABAN | Rivaroxaban SPC | 15 | Film-coated tablet | 251.60 | Details |
| RIVAROXABAN | Rivaroxaban SPC | 20 | Film-coated tablet | 179.60 | Details |
| MONTELUKAST SODIUM | Montas | 10 | Film-coated tablet | 38.1 | Details |
| BOSENTAN | Bosentan OHRE Pharma | 62.5 | Film-coated tablet | 5504.1 | Details |
| Dimethyl Fumarate | Dimethyl Fumarate SPC | 120 | Prolonged-release capsule, hard | 780 | Details |
| Dimethyl Fumarate | Dimethyl Fumarate SPC | 120 | Prolonged-release capsule, hard | 260 | Details |
| Dimethyl Fumarate | Dimethyl Fumarate SPC | 240 | Prolonged-release capsule, hard | 1560.149 | Details |
6.18% of users said yes from 275 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.